Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ESYT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HPS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSU72 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3R3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFP91 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC31A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAGA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABPB1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
EPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2C2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TET1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEL1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on